-
2024-514099-41-00
5
2024-10-31
Alzheimer's disease
-
2024-514240-93-00
10
2024-10-31
Idiopathic nephrotic syndrome (INS)
-
2024-514899-41-00
4
2024-10-31
Breast cancer
-
2024-511858-44-00
7
2024-10-24
Inclusion Body Myositis
-
2024-515300-39-00
4
2024-10-18
METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA OF G
-
2023-508012-35-00
5
2024-10-02
Newly diagnosed NSCLC with resectable clinical Stage II, IIIA or IIIB
-
2023-509073-23-00
4
2024-10-01
Stage III/IV non-small-cell lung cancer (NSCLC) harboring an ROS1 gene
-
2024-511070-68-01
5
2024-09-24
Ampullary adenocarcinoma
-
2023-507353-15-00
5
2024-09-10
idiopathic pulmonary fibrosis (IPF)
-
2024-515118-42-00
11
2024-09-10
Colorectal cancer
-
2022-502408-57-00
5
2024-09-04
Novo metastatic hormone-sensitive prostate cancer (mHSPC) patients hav
-
2024-517204-11-00
4
2024-08-30
microsatellite stable (MSS) colorectal cancer with liver-dominant meta
-
2024-515297-27-00
5
2024-08-14
colon carcinoma
-
2024-512872-36-00
5
2024-07-25
obstetric_pathological delivery
-
2023-509905-62-00
5
2024-07-19
Lower limb trauma requiring immobilisation
-
2023-505298-34-00
4
2024-07-18
Patients with dMMR/MSI (non-colorectal/non-endometrial) locally advanc
-
2024-514107-34-00
4
2024-07-18
BRAF V600E-MUTATED LOCALISED COLON OR UPPER RECTUM CANCER
-
2023-508162-15-00
5
2024-07-12
Chronic HF and comorbid impairment of kidney function who had a recent
-
2023-505112-38-00
11
2024-07-01
recently active non-infectious intermediate, posterior, and pan-uveiti
-
2024-514837-39-00
5
2024-07-01
Patients with obstructive sleep apnea syndrome with arterial
hypertens
-
2023-508100-38-00
5
2024-06-24
Advanced Biliary Cancer (ABC)
-
2023-506705-20-00
4
2024-06-14
relapsed or refractory patients with aggressive large B-cell lymphoma
-
2023-505436-35-00
5
2024-06-03
Untreated FLIPI 2-5 Follicular Lymphoma
-
2023-504486-23-00
5
2024-05-29
Venous thromboembolism